Skip to main
IQV

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 47%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

IQVIA Holdings demonstrated a positive financial outlook, as evidenced by year-over-year growth in key segments such as FSP, RWE, and CSMS, particularly noted in Q3. The company is experiencing momentum in its commercial operations, supported by improved client decision timelines, a robust pipeline fueled by recent drug launches, and a significant increase in request-for-proposal (RFP) flow. Additionally, IQVIA's confidence in achieving a 4%+ growth rate in its Research & Development Services (R&DS) segment, along with improvements in pricing dynamics and a stronger win rate, further underlines its favorable performance trajectory.

Bears say

The financial outlook for IQVIA Holdings appears to be negative due to several core issues. Year-over-year constant currency growth has declined from 6.8% to 3.8%, indicating potential challenges in maintaining revenue momentum, particularly with a projected slow down in real-world evidence due to tough comparisons. Additionally, rising interest rates may exert further downward pressure on earnings, compounded by a decreased hiring rate and an increasing reliance on passthroughs that are negatively impacting margins.

IQVIA Hlds (IQV) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 47% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 15 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Jan 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $243.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $243.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.